RxDoctor Payments Data

Heather Werlinger

Nurse Practitioner · Flint, MINPI 1124614219

Payments from drug & device makers

$1,753in general payments, 2019–2025

Across 81 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$286
  • Novo Nordisk$271
  • Lilly USA, LLC$253
  • AstraZeneca$247
  • AbbVie$207
  • Exact Sciences$150
  • plus $339 from 8 others

What the payments were for

  • Food & beverage$1,753100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,753 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$38,747
Medicare patients
182
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide61$61,377
OzempicSemaglutide52$61,299
EliquisApixaban39$54,290
JardianceEmpagliflozin29$31,247
TrulicityDulaglutide20$26,873
JanuviaSitagliptin Phosphate11$17,834
XareltoRivaroxaban13$17,316
Breo ElliptaFluticasone/Vilanterol17$9,371
Lantus SolostarInsulin Glargine,hum.Rec.Anlog61$7,194
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$4,478
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$3,749
Levothyroxine Sodium209$2,600
Atorvastatin Calcium179$2,578
Losartan Potassium135$2,189
Semglee (Yfgn) PenInsulin Glargine-Yfgn14$2,174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$253$88,24981 claims
Novo NordiskOzempic$271$61,29952 claims
PfizerEliquis$45$54,29039 claims
MerckJanuvia$41$17,83411 claims
GSKBreo Ellipta$71$9,37117 claims
Almatica Pharma LLCSertraline Hcl$24$75146 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →